| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | 0.29 | 8e-13 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.2 | 5e-12 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | 0.2 | 1e-10 |
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | 0.18 | 4e-10 |
| mRNA | AT-7519 | GDSC1000 | pan-cancer | AAC | 0.19 | 2e-09 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | 0.19 | 4e-09 |
| mRNA | decitabine:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.17 | 1e-08 |
| mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | 0.17 | 4e-08 |
| mRNA | Mitomycin-C | CTRPv2 | pan-cancer | AAC | 0.19 | 5e-08 |
| mRNA | WZ3105 | GDSC1000 | pan-cancer | AAC | 0.16 | 2e-07 |